Questcor Pharmacueticals (NASDAQ: QCOR) reported Q1 EPS of $0.61, $0.10 better than the analyst estimate of $0.51. Revenue for the quarter came in at $96 million versus the consensus estimate of $87.08 million.

For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.